Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
D000109:Acetylcholine; D000241:Adenosine; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000503:physiopathology*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017078:Laser-Doppler Flowmetry; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging; D005996:Nitroglycerin; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013577:Syndrome; D014664:Vasodilation; D014665:Vasodilator Agents
D014665:Vasodilator Agents; D005996:Nitroglycerin; D000241:Adenosine; D000109:Acetylcholine